Prediction: Eli Lilly's Latest Move Will Threaten AbbVie Stock

It'll be a while before there's any impact, but it could be a big deal.Eli Lilly's (LLY 0.42%) insatiable hunger to squeeze even more money out of its best-selling therapies is starting to look downright impressive. With its research and clinical groups firing on all cylinders, and management shoveling more funding into the fuel tank, the pace of its growth is more likely to accelerate than it is to slow down.And if the pharma's latest gambit pays off, it will probably start to put pressure on AbbVie (ABBV ...